Title	Publication Date	Language	Citations
Four-point Peritoneal Flap Fixation in Preventing Lymphocele Formation Following Radical Prostatectomy	2018/10/01	English	28
Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome—Results from the International Metastatic Renal Cell Carcinoma Database Consortium	2020/08/01	English	28
Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma	2020/08/01	English	28
Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer: A Phase II Randomized Controlled Trial	2022/10/01	English	27
Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer	2022/04/01	English	27
Preventing Osteoporosis in Men Taking Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis	2019/09/01	English	27
Theranostics for Advanced Prostate Cancer: Current Indications and Future Developments	2019/03/01	English	27
Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer	2018/06/01	English	27
Clinical Implications of Germline Testing in Newly Diagnosed Prostate Cancer	2021/02/01	English	27
PSMA-PET/CT–based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation Therapy	2021/02/01	English	27
Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non–muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysis	2020/06/01	English	26
Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific Differences	2020/08/01	English	26
European Association of Urology Guidelines on Primary Urethral Carcinoma—2020 Update	2020/08/01	English	26
Features and Prognostic Significance of Intraductal Carcinoma of the Prostate	2018/05/01	English	26
Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography–targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis	2022/08/01	English	26
Genetic Differences Between Bladder and Upper Urinary Tract Carcinoma: Implications for Therapy	2021/04/01	English	26
Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography with Computed Tomography for Lymph Node Staging in Patients with Upper Tract Urothelial Carcinoma	2020/02/01	English	26
Frailty and Greater Health Care Resource Utilization Following Major Urologic Oncology Surgery	2019/02/01	English	25
EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy	2022/10/01	English	25
Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours	2021/02/01	English	25
Updated European Association of Urology (EAU) Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin	2022/02/01	English	25
Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography–staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical Trial	2022/02/01	English	25
Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell Carcinoma	2022/02/01	English	25
Comparison of the Diagnostic Performance of Contrast-enhanced Ultrasound with That of Contrast-enhanced Computed Tomography and Contrast-enhanced Magnetic Resonance Imaging in the Evaluation of Renal Masses: A Systematic Review and Meta-analysis	2020/08/01	English	25
Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group	2020/06/01	English	25
Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers	2018/05/01	English	25
Staging 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Changes Treatment Recommendation in Invasive Bladder Cancer	2022/06/01	English	25
Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association with Clinical Outcomes: A Pilot Study	2020/10/01	English	24
Management of Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy: A Systematic Review of the Literature	2021/04/01	English	24
Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN)	2021/12/01	English	24